肿瘤微囊泡中microRNA-23a调节树突状细胞分化的作用机制

基本信息
批准号:81301794
项目类别:青年科学基金项目
资助金额:23.00
负责人:龚凤鸣
学科分类:
依托单位:四川大学
批准年份:2013
结题年份:2016
起止时间:2014-01-01 - 2016-12-31
项目状态: 已结题
项目参与者:彭星辰,沈国波,赵玉伟,罗灿,吴天明
关键词:
微囊泡直肠肿瘤C08_结miRNA23a免疫抑制DC
结项摘要

The production of microvesicles(MV) by tumor cells has been implicated in tumor associated immune suppression. We demonstrate that microvesicle by produce CT26 tumor cells inhibited the differentiation of myeloid dendritic cells (DC), promote DC cells apoptosis and reduce the absolute number cells. As a result, it damaged antigen uptake, antigen presented and secretion IL-12p70 of DC. MicroRNA (miRNA) chip found that miRNA-23a expression significantly improved in the MV; and DC phenotypic was changed after transfected miRNA-23a. Therefore, we inferred that miRNA-23a may regulate the DC cell differentiation and function without others reported. This study will reveal the mechanism miRNA-23a in tumor MV regulate DC cell function by integrating miRNA microarray, bioinformatics analysis, luciferase reporter gene and RNA interference research tools. These data will suggest that miRNA-23a in tumor MV regulate DC cell differentiation and function; and provide new ideas and choices for further investigate the mechanism, diagnosis and treatment of the tumor.

肿瘤分泌的微囊泡(Microvesicle, MV)在肿瘤微环境中起重要作用,MV可以降低免疫细胞活性,促进免疫耐受,发挥免疫抑制功能。本课题前期研究发现小鼠结直肠癌细胞分泌MV抑制髓系树突状细胞分化,促进DC细胞凋亡,降低DC细胞抗原摄取、递呈能力、IL-12p70分泌减少;miRNA芯片发现miRNA-23a在MV中明显富集,表达miRNA-23a慢病毒感染DC发现DC细胞表型改变,由此推测miRNA-23a可能调控髓系DC细胞分化,目前未见miRNA-23a调节DC功能的报道。本研究采用miRNA芯片、生物信息学分析、荧光素酶报告基因和RNAi干扰等研究手段,对肿瘤MV中miRNA-23a调节DC细胞功能及其靶基因进行研究,揭示其作用机制;丰富肿瘤MV中miRNA对DC细胞分化调控的理论,为探讨肿瘤发生机制及治疗提供新思路。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis

DOI:10.3390/cancers13174258
发表时间:2021
2

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

DOI:10.3389
发表时间:2021
3

基于图卷积网络的归纳式微博谣言检测新方法

基于图卷积网络的归纳式微博谣言检测新方法

DOI:10.3785/j.issn.1008-973x.2022.05.013
发表时间:2022
4

极地微藻对极端环境的适应机制研究进展

极地微藻对极端环境的适应机制研究进展

DOI:10.7685/jnau.201807013
发表时间:2019
5

结直肠癌肝转移患者预后影响

结直肠癌肝转移患者预后影响

DOI:10.3969 /j.issn.1002-266X.2016.23.023
发表时间:2016

龚凤鸣的其他基金

相似国自然基金

1

功能化树突状细胞膜囊泡介导肝癌免疫治疗的机制研究

批准号:81801817
批准年份:2018
负责人:曾云
学科分类:H2809
资助金额:21.00
项目类别:青年科学基金项目
2

囊泡定向转运对CDC42在胞内的极性定位及其对树突状细胞功能的调节

批准号:30900720
批准年份:2009
负责人:王璞玥
学科分类:C0701
资助金额:18.00
项目类别:青年科学基金项目
3

α-黑素细胞刺激素调节树突状细胞分化成熟作用的分子机制

批准号:30771991
批准年份:2007
负责人:田野苹
学科分类:C0801
资助金额:30.00
项目类别:面上项目
4

核受体LXR调控树突状细胞分化的机制及其在肿瘤中的病理意义

批准号:81072397
批准年份:2010
负责人:周洁
学科分类:H1101
资助金额:38.00
项目类别:面上项目